The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of neratinib for HER2 mutated, non-amplified metastatic breast cancer (HER2mut MBC).
 
Cynthia X. Ma
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Novartis
 
Ron Bose
Honoraria - Genentech
Consulting or Advisory Role - Genentech
 
Feng Gao
No Relationships to Disclose
 
Rachel A. Freedman
Research Funding - Eisai (Inst); Genentech (Inst); Puma Biotechnology (Inst)
 
Mark D. Pegram
Employment - Dava Oncology (I)
Consulting or Advisory Role - Genenetech, Pfizer, Novartis, AstraZeneca
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Genentech, Pfizer, Novartis
Other Relationship - Genentech, Pfizer, Novartis, AstraZeneca
 
Kimberly Blackwell
Consulting or Advisory Role - Amgen; Celgene; Genentech; Incyte; Lilly; Novartis; Pfizer; Roche; Sandoz; Spectrum Pharmaceuticals
Research Funding - Celgene (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Philippe L. Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)
 
Daniel F. Hayes
Stock and Other Ownership Interests - InBiomotion; OncImmune
Honoraria - 3rd UK Breast Cancer Meeting, Londong; Lilly
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca (Inst); Janssen Research & Development (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Circulating Tumor Cell Capturing Techniques and Devices. Patent No.: US 8,951,484 B2. Date of Patent: Feb. 10, 2015. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor.; Diagnosis and Treatment of Breast Cancer. Patent No. US 8,790,878 B2. Date of Patent: Jul. 29, 2014. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor.; Royalties from licensed technology.; Title: A method for predicting progression free and overall survival at each follow-up timepoint during therapy of metastatic breast cancer patients using circulating tumor cells. Patent no. 05725638.0-1223-US2005008602.
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Lilly
 
Polly Ann Niravath
No Relationships to Disclose
 
Christy Ann Russell
Honoraria - Genentech/Roche; Genomic Health; Novartis; Pfizer
Speakers' Bureau - Genentech/Roche; Genomic Health; Novartis; Pfizer
Travel, Accommodations, Expenses - Genentech/Roche; Genomic Health; Novartis; Pfizer
 
Debu Tripathy
Consulting or Advisory Role - Merck; Nektar; Novartis; Oncoplex Diagnostics; Pfizer
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Melody A. Cobleigh
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Genentech (Inst); Macrogenics (Inst); Merrimack (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Genomic Health
 
Andres Forero
No Relationships to Disclose
 
Timothy J. Pluard
Consulting or Advisory Role - Bayer/Onyx
Speakers' Bureau - Genentech/Roche; NanoString Technologies
 
Carey K. Anders
Consulting or Advisory Role - BiPar Sciences; Genentech/Roche; GERON; Lilly; Merrimack; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem; BiPar Sciences; Bristol-Myers Squibb; Geron; Merrimack; Novartis; Puma Biotechnology; Sanofi; to-BBB technologies BV
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Caroline Bumb
No Relationships to Disclose
 
Michael Naughton
Honoraria - Amgen; BCI Pharma; Celgene; Genentech; Novartis
Consulting or Advisory Role - BC Cancer Agency; Celgene; Genentech; Novartis
Speakers' Bureau - Amgen; BCI Pharma; Celgene; Genentech; Novartis
Travel, Accommodations, Expenses - Amgen; BCI Pharma; Celgene; Genentech; Novartis
 
Hussam Al-Kateb
No Relationships to Disclose
 
Matthew James Ellis
Employment - Bioclassifier
Leadership - Bioclassifier
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - AstraZeneca; Celgene; NanoString Technologies; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent on PAM50, which generates royalties on the license to Bioclassifier/Prosigna/Nanostring
Travel, Accommodations, Expenses - AstraZeneca; Pfizer